{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:02:45Z","timestamp":1790107365117,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006260","name":"Technion - Israel Institute of Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006260","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To compare long-term results of different treatment modalities in central giant cell granuloma of the maxillofacial-skeleton. Primary resection may result in major defects. Alternative treatments include pharmacological agents. As yet there has been no consensus on the use of the variety of treatment options, and few studies have reported clarifying long-term results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This retrospective study on 22 patients with 25 lesions evaluated clinical, radiological and histological features, treatment preformed and lesion recurrence. Success was defined as regression\/calcification and failure as recurrence, progression or un-responsiveness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the presenting patients, 77% were under age 40. Lesion prevalence was higher in the anterior mandible and left posterior maxilla. Most cases exhibited pain, tooth-mobility or mucosal-expansion. The appearance was predominantly unilocular in the maxilla and multilocular in the mandible, which also exhibited higher prevalence of cortical perforation. Up to 80% of lesions were classified as aggressive.<\/jats:p>\n                <jats:p>Intralesional steroids\/calcitonin were used in 7 cases. Mean follow-up was 39.8 months. Two cases showed recurrence. In 71% of the cases treated pharmacologically, calcification\/regression were observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our analysis indicates better outcomes using a combined approach, including both pharmacological and surgical treatments in large aggressive lesions. Pharmacological treatment resulted in decreased size or well-defined lesions, thus reducing the need for extensive bone resection. Dual treatment with corticosteroids and calcitonin showed no superior outcomes, but a larger cohort should be assessed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical Relevance<\/jats:title>\n                <jats:p>There are several protocols for treatment of central-giant-cell-granuloma lesions, but most are not fully established. It is important to report results that contribute to the establishment of proven protocols. This report attempts to establish the relevance of the combined approach: pharmacological treatment followed by surgical resection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00784-024-05585-7","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T23:01:36Z","timestamp":1709852496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Central giant cell granuloma of the jaws\u2014long-term clinical and radiological outcomes of surgical and pharmacological management"],"prefix":"10.1007","volume":"28","author":[{"given":"Tal","family":"Capucha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Krasovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragda","family":"Abdalla-Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiriys George","family":"Ginini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani","family":"Noy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omri","family":"Emodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Rachmiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekel","family":"Shilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"5585_CR1","volume-title":"Oral and Maxillofacial Pathology","author":"B Neville","year":"1995","unstructured":"Neville B, Damm D, Allen C, Bouquot J (1995) Oral and Maxillofacial Pathology. Saunders, Philadelphia"},{"key":"5585_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-02858-2","volume-title":"Histological typing of odontogenic tumours","author":"IRHPJ Kramer","year":"1992","unstructured":"Kramer IRHPJ, Shear M (1992) Histological typing of odontogenic tumours. Springer, Berlin"},{"key":"5585_CR3","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1148\/radiographics.21.5.g01se251283","volume":"21","author":"MD Murphey","year":"2001","unstructured":"Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ (2001) Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. Radiographics 21:1283\u20131309","journal-title":"Radiographics"},{"key":"5585_CR4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0030-4220(93)90094-K","volume":"75","author":"SB Whitaker","year":"1993","unstructured":"Whitaker SB, Waldron CA (1993) Central giant cell lesions of the jaws: a clinical, radiologic, and histopathologic study. Oral Surg Oral Med Oral Pathol 75:199\u2013208","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"5585_CR5","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1079-2104(96)80079-5","volume":"81","author":"I Kaffe","year":"1996","unstructured":"Kaffe I, Ardekian L, Taicher S, Littner MM, Buchner A (1996) Radiologic features of central giant cell granuloma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 81:720\u2013726","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5585_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/0278-2391(86)90040-6","volume":"44","author":"R Chuong","year":"1986","unstructured":"Chuong R, Kaban LB, Kozakewich H, Perez-Atayde A (1986) Central giant cell lesions of the jaws: a clinicopathologic study. J Oral Maxillofac Surg 44:708\u2013713","journal-title":"J Oral Maxillofac Surg"},{"key":"5585_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.tripleo.2007.04.003","volume":"104","author":"J de Lange","year":"2007","unstructured":"de Lange J, van den Akker HP, van den Berg H (2007) Central giant cell granuloma of the jaw: a review of the literature with emphasis on therapy options. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:603\u2013615","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5585_CR8","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.joms.2007.06.680","volume":"66","author":"R Gonz\u00e1lez-Garc\u00eda","year":"2008","unstructured":"Gonz\u00e1lez-Garc\u00eda R, Naval-G\u00edas L, Rodr\u00edguez-Campo FJ, Mart\u00ednez-Chac\u00f3n JL, Usandizaga JLG-D (2008) Vascularized fibular flap for reconstruction of the condyle after mandibular ablation. J Oral Maxillofac Surg 66:1133\u20131137","journal-title":"J Oral Maxillofac Surg"},{"key":"5585_CR9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jcms.2009.04.002","volume":"37","author":"P Tosco","year":"2009","unstructured":"Tosco P, Tanteri G, Iaquinta C, Fasolis M, Roccia F, Berrone S, Garzino-Demo P (2009) Surgical treatment and reconstruction for central giant cell granuloma of the jaws: a review of 18 cases. J Cranio-Maxillofac Surg 37:380\u2013387","journal-title":"J Cranio-Maxillofac Surg"},{"key":"5585_CR10","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ijom.2006.03.030","volume":"35","author":"J De Lange","year":"2006","unstructured":"De Lange J, Van den Akker H, Van Zanten GV, Engelshove H, Van den Berg H, Klip H (2006) Calcitonin therapy in central giant cell granuloma of the jaw: a randomized double-blind placebo-controlled study. Int J Oral Maxillofac Surg 35:791\u2013795","journal-title":"Int J Oral Maxillofac Surg"},{"key":"5585_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/joms.2003.50130","volume":"61","author":"LB Kaban","year":"2003","unstructured":"Kaban LB, Dodson TB (2003) Clinical articles-discussion-calcitonin therapy for central giant cell granuloma. J Oral Maxillofac Surg 61:653\u2013654","journal-title":"J Oral Maxillofac Surg"},{"key":"5585_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/joms.2003.50129","volume":"61","author":"M Pogrel","year":"2003","unstructured":"Pogrel M (2003) Calcitonin therapy for central giant cell granuloma. J Oral Maxillofac Surg 61:649\u2013653","journal-title":"J Oral Maxillofac Surg"},{"key":"5585_CR13","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0278-2391(99)90828-5","volume":"57","author":"MA Pogrel","year":"1999","unstructured":"Pogrel MA, Regezi JA, Harris ST, Goldring SR (1999) Calcitonin treatment for central giant cell granulomas of the mandible: report of two cases. J Oral Maxillofac Surg 57:848\u2013853","journal-title":"J Oral Maxillofac Surg"},{"key":"5585_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tripleo.2006.05.020","volume":"104","author":"M Vered","year":"2007","unstructured":"Vered M, Shohat I, Buchner A, Dayan D, Taicher S (2007) Calcitonin nasal spray for treatment of central giant cell granuloma: clinical, radiological, and histological findings and immunohistochemical expression of calcitonin and glucocorticoid receptors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104:226\u2013239","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5585_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bjoms.2004.08.015","volume":"43","author":"EN Abdo","year":"2005","unstructured":"Abdo EN, Alves LCF, Rodrigues AS, Mesquita RA, Gomez RS (2005) Treatment of a central giant cell granuloma with intralesional corticosteroid. Br J Oral Maxillofac Surg 43:74\u201376","journal-title":"Br J Oral Maxillofac Surg"},{"key":"5585_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1067\/moe.2002.119971","volume":"93","author":"R Carlos","year":"2002","unstructured":"Carlos R, Sedano HO (2002) Intralesional corticosteroids as an alternative treatment for central giant cell granuloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:161\u2013166","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5585_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bjoms.2008.05.013","volume":"47","author":"J de Lange","year":"2009","unstructured":"de Lange J, van Rijn RR, van den Berg H, van den Akker HP (2009) Regression of central giant cell granuloma by a combination of imatinib and interferon: a case report. Br J Oral Maxillofac Surg 47:59\u201361","journal-title":"Br J Oral Maxillofac Surg"},{"key":"5585_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1542\/peds.103.6.1145","volume":"103","author":"LB Kaban","year":"1999","unstructured":"Kaban LB, Mulliken JB, Ezekowitz RA, Phil D, Ebb D, Smith PS, Folkman J (1999) Antiangiogenic therapy of a recurrent giant cell tumor of the mandible with interferon alfa-2a. Pediatrics 103:1145\u20131149","journal-title":"Pediatrics"},{"key":"5585_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.joms.2017.09.013","volume":"76","author":"M Bredell","year":"2018","unstructured":"Bredell M, Rordorf T, Kroiss S, R\u00fccker M, Zweifel DF, Rostetter C (2018) Denosumab as a treatment alternative for central giant cell granuloma: a long-term retrospective cohort study. J Oral Maxillofac Surg 76:775\u2013784","journal-title":"J Oral Maxillofac Surg"},{"key":"5585_CR20","first-page":"572","volume":"66","author":"J Jacoway","year":"1988","unstructured":"Jacoway J (1988) Central giant cell granuloma-an alternative to surgical therapy. Oral Surg Oral Med Oral Pathol 66:572","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"5585_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0266-4356(93)90168-V","volume":"31","author":"M Harris","year":"1993","unstructured":"Harris M (1993) Central giant cell granulomas of the jaws regress with calcitonin therapy. Br J Oral Maxillofac Surg 31:89\u201394","journal-title":"Br J Oral Maxillofac Surg"},{"key":"5585_CR22","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.joms.2007.03.030","volume":"65","author":"LB Kaban","year":"2007","unstructured":"Kaban LB, Troulis MJ, Wilkinson MJ, Ebb D, Dodson TB (2007) Adjuvant antiangiogenic therapy for giant cell tumors of the jaws. J Oral Maxillofac Surg 65:2018\u20132024","journal-title":"J Oral Maxillofac Surg"},{"key":"5585_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1053\/joms.2002.34975","volume":"60","author":"LB Kaban","year":"2002","unstructured":"Kaban LB, Troulis MJ, Ebb D, August M, Hornicek FJ, Dodson TB (2002) Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg 60:1103\u20131111","journal-title":"J Oral Maxillofac Surg"},{"key":"5585_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.tripleo.2009.02.013","volume":"107","author":"DM Allon","year":"2009","unstructured":"Allon DM, Anavi Y, Calderon S (2009) Central giant cell lesion of the jaw: nonsurgical treatment with calcitonin nasal spray. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:811\u2013818","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5585_CR25","volume-title":"Oral and maxillofacial pathology: a rationale for diagnosis and treatment","author":"RE Marx","year":"2012","unstructured":"Marx RE, Stern D (2012) Oral and maxillofacial pathology: a rationale for diagnosis and treatment. Quintessence Pub. Co., Hanover Park (IL)"},{"key":"5585_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tripleo.2004.11.024","volume":"100","author":"KE Goldman","year":"2005","unstructured":"Goldman KE, Marshall MK, Alessandrini E, Bernstein ML (2005) Complications of alpha-interferon therapy for aggressive central giant cell lesion of the maxilla. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:285\u2013291","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"5585_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jop.12730","volume":"47","author":"BR Chrcanovic","year":"2018","unstructured":"Chrcanovic BR, Gomes CC, Gomez RS (2018) Central giant cell lesion of the jaws: an updated analysis of 2270 cases reported in the literature. J Oral Pathol Med 47:731\u2013739","journal-title":"J Oral Pathol Med"},{"key":"5585_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S1042-3699(20)30771-8","volume":"6","author":"B Terry","year":"1994","unstructured":"Terry B, Jacoway J (1994) Management of central giant cell lesions: an alternative to surgical therapy. Oral Maxillofac Surg Clin North Am 6:579\u2013600","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"5585_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jcms.2016.11.011","volume":"45","author":"WH Schreuder","year":"2017","unstructured":"Schreuder WH, van den Berg H, Westermann AM, Peacock ZS, de Lange J (2017) Pharmacological and surgical therapy for the central giant cell granuloma: a long-term retrospective cohort study. J Cranio-Maxillofac Surg 45:232\u2013243","journal-title":"J Cranio-Maxillofac Surg"},{"key":"5585_CR30","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/oncolo\/oyad196","volume":"28","author":"A Lipplaa","year":"2023","unstructured":"Lipplaa A, Schreuder WH, Pichardo SE, Gelderblom H (2023) Denosumab in giant cell rich tumors of bone: an open-label multicenter phase II study. Oncologist 28:1005-e1104","journal-title":"Oncologist"},{"key":"5585_CR31","doi-asserted-by":"publisher","first-page":"108980","DOI":"10.1016\/j.ijscr.2023.108980","volume":"112","author":"P Klienkoff","year":"2023","unstructured":"Klienkoff P, Weingertner N, Geyer L, Gros C-I, Kurtz J-E, Bornert F (2023) Management of a rare mandibular giant cell tumor of bone by neoadjuvant denosumab therapy and surgery: a 4-year follow-up case report. Int J Surg Case Rep 112:108980","journal-title":"Int J Surg Case Rep"},{"key":"5585_CR32","doi-asserted-by":"crossref","unstructured":"Liu X, Xie Y, Tang J, Zhong J, Lan D (2023) Hypercalcemia in children following a discontinuation of denosumab therapy: a case report and literature review. Clin Pediatr 0(0)","DOI":"10.1177\/00099228231194427"},{"key":"5585_CR33","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s00264-017-3536-9","volume":"41","author":"C Errani","year":"2017","unstructured":"Errani C, Tsukamoto S, Mavrogenis AF (2017) How safe and effective is denosumab for bone giant cell tumour? Int Orthop 41:2397\u20132400. https:\/\/doi.org\/10.1007\/s00264-017-3536-9","journal-title":"Int Orthop"}],"updated-by":[{"DOI":"10.1007\/s00784-024-05622-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000}}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-024-05585-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-024-05585-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-024-05585-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T02:12:07Z","timestamp":1711937527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-024-05585-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["5585"],"URL":"https:\/\/doi.org\/10.1007\/s00784-024-05585-7","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00784-024-05622-5","asserted-by":"object"}]},"ISSN":["1436-3771"],"issn-type":[{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"21 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00784-024-05622-5","URL":"https:\/\/doi.org\/10.1007\/s00784-024-05622-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study followed the Declaration of Helsinki on medical protocol and ethics and the Institutional Ethical Review Board approved the study. Approval ref. 0322\u201320-RMB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"200"}}